Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).

[1]  R. Gibbons,et al.  Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial , 2005 .

[2]  B. Gersh,et al.  Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. , 2005, Journal of the American College of Cardiology.

[3]  R. Giugliano,et al.  Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. , 2004, Journal of the American College of Cardiology.

[4]  H. Suryapranata,et al.  Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. , 2003, Journal of the American College of Cardiology.

[5]  B. Rutherford,et al.  Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years. , 2003, American heart journal.

[6]  A. Hamsten,et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.

[7]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[8]  George Dangas,et al.  Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. , 2002, Journal of the American College of Cardiology.

[9]  T D Miller,et al.  Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. , 2000, Circulation.

[10]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[11]  S. Fava,et al.  Outcome of Unstable Angina in Patients with Diabetes Mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[12]  K Wegscheider,et al.  Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. , 1995, Journal of the American College of Cardiology.

[13]  J. Cruz,et al.  Transient myocardial injury after elective electrical cardioversion. , 1994, International journal of cardiology.

[14]  K. Wegscheider,et al.  Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.

[15]  J. Herlitz,et al.  One‐year prognosis in patients hospitalized with a history of unstable angina pectoris , 1993, Clinical cardiology.

[16]  R. Califf,et al.  Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. , 1993, The American journal of cardiology.

[17]  M. Hori,et al.  Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. , 2003, Journal of the American College of Cardiology.